These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20697161)

  • 1. Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient.
    Al-Qadheeb NS; Althawadi S; Alkhalaf A; Hosaini S; Alrajhi AA
    Ann Saudi Med; 2010; 30(5):404-7. PubMed ID: 20697161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Spanu T; De Angelis G; Cipriani M; Pedruzzi B; D'Inzeo T; Cataldo MA; Sganga G; Tacconelli E
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4516-8. PubMed ID: 22644031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients.
    Balandin Moreno B; Fernández Simón I; Pintado García V; Sánchez Romero I; Isidoro Fernández B; Romera Ortega MA; Alcántara Carmona S; Pérez Redondo M; Galdos Anuncibay P
    Scand J Infect Dis; 2014 Mar; 46(3):175-80. PubMed ID: 24354959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
    Ni W; Li G; Zhao J; Cui J; Wang R; Gao Z; Liu Y
    Infect Dis (Lond); 2018 Jul; 50(7):507-513. PubMed ID: 29316830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
    Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ
    Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline.
    Anthony KB; Fishman NO; Linkin DR; Gasink LB; Edelstein PH; Lautenbach E
    Clin Infect Dis; 2008 Feb; 46(4):567-70. PubMed ID: 18199038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae.
    Daly MW; Riddle DJ; Ledeboer NA; Dunne WM; Ritchie DJ
    Pharmacotherapy; 2007 Jul; 27(7):1052-7. PubMed ID: 17594211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.
    Hirsch EB; Tam VH
    J Antimicrob Chemother; 2010 Jun; 65(6):1119-25. PubMed ID: 20378670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.
    De Rosa FG; Corcione S; Cavallo R; Di Perri G; Bassetti M
    Future Microbiol; 2015; 10(2):283-94. PubMed ID: 25689539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of tigecycline, polymyxin, gentamicin, meropenem and associations in experimental Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae non-lethal sepsis.
    Toledo PV; Tuon FF; Arend L; Aranha Junior AA
    Braz J Infect Dis; 2014; 18(5):574-5. PubMed ID: 24907469
    [No Abstract]   [Full Text] [Related]  

  • 11. Extended-spectrum beta-lactamase Klebsiella pneumoniae meningitis treated with tigecycline.
    Wadi JA; Selawi F
    Ann Saudi Med; 2009; 29(3):239-40. PubMed ID: 19448375
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term, low-dose tigecycline to treat relapsing bloodstream infection due to KPC-producing Klebsiella pneumoniae after major hepatic surgery.
    Morelli L; Tartaglia D; Furbetta N; Palmeri M; Ferranti S; Tagliaferri E; Di Candio G; Mosca F
    Int J Infect Dis; 2015 Jul; 36():4-5. PubMed ID: 25975648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended antibiotic resistance in carbapenemase-producing Klebsiella pneumoniae: A case series.
    Walker CD; Shankaran S
    Am J Infect Control; 2016 Sep; 44(9):1050-2. PubMed ID: 27079242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of monomicrobial intraabdominal abscesses due to KPC--3 Klebsiella pneumoniae ST258 clone.
    Di Carlo P; Pantuso G; Cusimano A; D'Arpa F; Giammanco A; Gulotta G; Latteri AM; Madonia S; Salamone G; Mammina C
    BMC Gastroenterol; 2011 Sep; 11():103. PubMed ID: 21961811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlling infection and spread of carbapenems-resistant Klebsiella pneumoniae among burn patients].
    Huan J
    Zhonghua Shao Shang Za Zhi; 2015 Feb; 31(1):5-8. PubMed ID: 25876631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of tigecycline- and carbapenem-nonsusceptible Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline.
    Sheng ZK; Wang W; Guo Q; Xu X; Wang M; Yang Y; Wang M
    J Microbiol Immunol Infect; 2016 Dec; 49(6):962-968. PubMed ID: 26692183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.
    Camargo JF; Simkins J; Beduschi T; Tekin A; Aragon L; Pérez-Cardona A; Prado CE; Morris MI; Abbo LM; Cantón R
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5903-8. PubMed ID: 26386029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Resistance Mechanism and Clonal Distribution of Tigecycline-Nonsusceptible Klebsiella pneumoniae Isolates in Korea.
    Ahn C; Yoon SS; Yong TS; Jeong SH; Lee K
    Yonsei Med J; 2016 May; 57(3):641-6. PubMed ID: 26996563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Klebsiella spp. to tigecycline and other selected antibiotics.
    Sekowska A; Gospodarek E
    Med Sci Monit; 2010 Jun; 16(6):BR193-6. PubMed ID: 20512088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
    Conejo MC; Hernández JR; Pascual A
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.